Colfax Corporation (CFXA)
|52 Week Range||176.8325-185.61|
|1y Target Est||-|
|DCF Unlevered||CFXA DCF ->|
|DCF Levered||CFXA LDCF ->|
|Debt / Equity||83.47%||Buy|
Upgrades & Downgrades
Latest CFXA news
Forget The Covid Apocalypse, Focus On Stocks That Closed Green After Friday's Monster Sell Off
28 November 2021
Sharp sell-offs can reveal great stock ideas if you surface the right stocks that contrary to the market action close positive. When picking names that close in the green, make sure they are well know...
Is Now An Opportune Moment To Examine Colfax Corporation (NYSE:CFX)?
10 August 2020
Colfax Corporation (NYSE:CFX), is not the largest company out there, but it led the NYSE gainers with a relatively...
At US$33.31, Is It Time To Put Colfax Corporation (NYSE:CFX) On Your Watch List?
10 August 2020
While Colfax Corporation (NYSE:CFX) might not be the most widely known stock at the moment, it saw a significant share...
Colfax (CFX) Tops Q2 Earnings Estimates, Gives Impressive View
7 August 2020
Colfax's (CFX) Q2 results reflect the adverse impacts of the pandemic on product demand and forex woes. It predicts generating sequentially higher profits and positive cash flow in Q3.
DJO® Revolutionizes the Orthopedic Journey with the Launch of Motion iQ™
6 August 2020
DJO, LLC ("DJO" or the "Company"), a leading global provider of medical technologies to get and keep people moving, introduces Motion iQ™, an innovative new software solution designed to transform the...
Colfax (CFX) Beats Q2 Earnings and Revenue Estimates
6 August 2020
Colfax (CFX) delivered earnings and revenue surprises of 50.00% and 2.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Colfax Reports Second Quarter 2020 Results
6 August 2020
• Achieved objectives to address COVID-19 impacts, including generating positive cash flow• Reported $(0.03) EPS from continuing operations and achieved $0.09 of adjusted EPS • ...
Analysts Estimate Colfax (CFX) to Report a Decline in Earnings: What to Look Out for
30 July 2020
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colfax (CFX) Shares Gain 41% in 3 Months: What's Driving It?
20 July 2020
Colfax (CFX), with 41% growth in shares in the past three months, benefits from the overall revival in the broader market, buyout impacts, solid product offerings and cost-saving measures.
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >